Interestingly, Schmidt and coworkers[60] suggested that Iqgap2 acts as a tumor suppressor, and its loss can lead to β-catenin activation and the development of HCC, and this finding further implicates β-catenin as a key driver of HCC. The gene discussed is IQGAP2; the disease is hepatocellular carcinoma.